| MeSH term | MeSH ID | Detail |
|---|---|---|
| Exanthema | D005076 | 11 associated lipids |
| Thromboembolism | D013923 | 6 associated lipids |
| Vitamin K Deficiency | D014813 | 5 associated lipids |
Total
3
phylloquinone
Phylloquinone is a lipid of Prenol Lipids (PR) class. Phylloquinone is associated with abnormalities such as Vitamin K Deficiency, Malnutrition, Consumption-archaic term for TB, Osteoporosis and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Ingestion, Blood Circulation, Genetic Polymorphism, Intestinal Absorption and Process. Phylloquinone often locates in Blood, Body tissue, Hepatic, Membrane and Entire bony skeleton. The associated genes with phylloquinone are Vitamin K Epoxide Reductase Complex, Subunit 1, GGCX gene, CYP4F2 gene, Alleles and APOE gene. The related lipids are Micelles, 208-G, Fatty Acids, Total cholesterol and Sphingolipids. The related experimental models are Knock-out.
Cross Reference
Introduction
To understand associated biological information of phylloquinone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with phylloquinone?
phylloquinone is suspected in Vitamin K Deficiency, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes, vitamin depletion, Malnutrition, Osteoporosis and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with phylloquinone
PubChem Associated disorders and diseases
What pathways are associated with phylloquinone
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with phylloquinone?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with phylloquinone?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with phylloquinone?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with phylloquinone?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with phylloquinone?
Knock-out
Knock-out are used in the study 'A dedicated thioesterase of the Hotdog-fold family is required for the biosynthesis of the naphthoquinone ring of vitamin K1.' (Widhalm JR et al., 2009) and Knock-out are used in the study 'Deficiency in phylloquinone (vitamin K1) methylation affects prenyl quinone distribution, photosystem I abundance, and anthocyanin accumulation in the Arabidopsis AtmenG mutant.' (Lohmann A et al., 2006).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with phylloquinone
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Kurnik D et al. | Over-the-counter vitamin K1-containing multivitamin supplements disrupt warfarin anticoagulation in vitamin K1-depleted patients. A prospective, controlled trial. | 2004 | Thromb. Haemost. | pmid:15543329 |
| Bechtold H et al. | Evidence for impaired hepatic vitamin K1 metabolism in patients treated with N-methyl-thiotetrazole cephalosporins. | 1984 | Thromb. Haemost. | pmid:6548584 |
| Rost S et al. | Site-directed mutagenesis of coumarin-type anticoagulant-sensitive VKORC1: evidence that highly conserved amino acids define structural requirements for enzymatic activity and inhibition by warfarin. | 2005 | Thromb. Haemost. | pmid:16270630 |
| Kamali F et al. | The influence of (R)- and (S)-warfarin, vitamin K and vitamin K epoxide upon warfarin anticoagulation. | 2000 | Thromb. Haemost. | pmid:10928467 |
| Booth SL et al. | Dietary vitamin K1 and stability of oral anticoagulation: proposal of a diet with constant vitamin K1 content. | 1997 | Thromb. Haemost. | pmid:9066002 |
| Lefrère JJ and Girot R | Acute cardiovascular collapse during intravenous vitamin K1 injection. | 1987 | Thromb. Haemost. | pmid:3672431 |
| Braam LA et al. | Beneficial effects of vitamins D and K on the elastic properties of the vessel wall in postmenopausal women: a follow-up study. | 2004 | Thromb. Haemost. | pmid:14961167 |
| Zolcinski M et al. | Intoxication with three different superwarfarin compounds in an adult woman. | 2008 | Thromb. Haemost. | pmid:18612553 |
| Denas G et al. | An oral vitamin K protocol to reverse over-anticoagulation in patients presenting with an International Normalised Ratio above 10.0. | 2009 | Thromb. Haemost. | pmid:19190831 |
| Shearer MJ and Newman P | Metabolism and cell biology of vitamin K. | 2008 | Thromb. Haemost. | pmid:18841274 |
| Ghosh K et al. | Congenital deficiency of vitamin K dependent coagulation factors--its rarity and need for an international registry. | 2001 | Thromb. Haemost. | pmid:11686345 |
| Kohlmeier M et al. | Variation of phylloquinone (vitamin K1) concentrations in hemodialysis patients. | 1995 | Thromb. Haemost. | pmid:8607104 |
| von Kries R et al. | Des-gamma-carboxyprothrombin (PIVKA II) and plasma vitamin K1 in newborns and their mothers. | 1992 | Thromb. Haemost. | pmid:1448768 |
| Hagstrom JN et al. | The pharmacokinetics and lipoprotein fraction distribution of intramuscular vs. oral vitamin K1 supplementation in women of childbearing age: effects on hemostasis. | 1995 | Thromb. Haemost. | pmid:8772225 |
| von Kries R and Hanawa Y | Neonatal vitamin K prophylaxis. Report of Scientific and Standardization Subcommittee on Perinatal Haemostasis. | 1993 | Thromb. Haemost. | pmid:8470054 |
| van Oosterom AT et al. | The influence of the thyroid function on the metabolic rate of prothrombin, factor VII, and factor X in the rat. | 1976 | Thromb. Haemost. | pmid:989968 |
| Shetty HG et al. | Effective reversal of warfarin-induced excessive anticoagulation with low dose vitamin K1. | 1992 | Thromb. Haemost. | pmid:1615468 |
| Yamanaka Y et al. | Effect of warfarin on plasma and liver vitamin K levels and vitamin K epoxide reductase activity in relation to plasma clotting factor levels in rats. | 1990 | Thromb. Res. | pmid:2315885 |
| Raith W et al. | Plasma concentrations after intravenous administration of phylloquinone (vitamin K(1)) in preterm and sick neonates. | 2000 | Thromb. Res. | pmid:10973675 |
| Creedon KA and Suttie JW | Effect of N-methyl-thiotetrazole on vitamin K epoxide reductase. | 1986 | Thromb. Res. | pmid:3787564 |
| Jamison CS and Degen SJ | Non-specific effects of aquaMEPHYTON (vitamin K1) on prothrombin expression in human hepatoblastoma (HepG2) cells. | 1992 | Thromb. Res. | pmid:1321512 |
| Majeed H et al. | Effect of 200μG/day of vitamin K1 on the variability of anticoagulation control in patients on warfarin: a randomized controlled trial. | 2013 | Thromb. Res. | pmid:23953594 |
| Giuliano V et al. | Small intestinal bacterial overgrowth and warfarin dose requirement variability. | 2010 | Thromb. Res. | pmid:20051286 |
| Schäfer H and Matthias FR | Relationship between vitamin K1 2,3-epoxide and vitamin K1 in patients treated with N-methyl-thiotetrazole cephalosporins. | 1992 | Thromb. Res. | pmid:1631806 |
| MAKI M and TAKANO A | A CASE OF MENORRHAGE COMBINED WITH HYPOFIBRINOGENEMIA. | 1963 | Tohoku J. Exp. Med. | pmid:14077062 |
| Webster WS et al. | Measurement of DNA damage by the comet assay in rat embryos grown in media containing high concentrations of vitamin K(1). | 2000 | Toxicol In Vitro | pmid:10699366 |
| Tirapelli CR et al. | Vitamin K1 (phylloquinone) induces vascular endothelial dysfunction: role of oxidative stress. | 2006 | Toxicol. Appl. Pharmacol. | pmid:16256160 |
| Wilson CR et al. | Species comparison of vitamin K1 2,3-epoxide reductase activity in vitro: kinetics and warfarin inhibition. | 2003 | Toxicology | pmid:12832152 |
| Alparin JB | Transfusion medicine issues in the practice of anesthesiology. | 1995 | Transfus Med Rev | pmid:8541716 |
| Holzer G et al. | Vitamin K epoxide reductase (VKORC1) gene mutations in osteoporosis: A pilot study. | 2010 | Transl Res | pmid:20621035 |
| Hauska G | Phylloquinone in photosystem I: are quinones the secondary electron acceptors in all types of photosynthetic reaction centers? | 1988 | Trends Biochem. Sci. | pmid:3075361 |
| Iijima T and Nambu M | Effect of combination therapy of vitamin K1 and ursodeoxycholic acid on liver function tests. | 1988 Jul-Aug | Trop Gastroenterol | pmid:3194959 |
| Karaca M et al. | [On an uncommon coagulation defect in patients receiving oral anticoagulants]. | 1967 | Turk Tip Cemiy Mecm | pmid:6082060 |
| Hansen HH | [Practical aspects of peroral anticoagulant treatment]. | 2001 | Ugeskr. Laeg. | pmid:11794049 |
| Bakaev VV and Khomenko VF | [Vitamin K1 and C metabolism in uremia during hemodialysis]. | 1991 Jan-Feb | Urol Nefrol (Mosk) | pmid:1858205 |
| Sheen SR et al. | Symptomatic brodifacoum ingestion requiring high-dose phytonadione therapy. | 1994 | Vet Hum Toxicol | pmid:8066968 |
| Thom N et al. | Nonuraemic nonfatal idiopathic calciphylaxis in a kitten. | 2013 | Vet. Dermatol. | pmid:23930985 |
| Oldenburg J et al. | The vitamin K cycle. | 2008 | Vitam. Horm. | pmid:18374189 |
| Tie JK and Stafford DW | Structure and function of vitamin K epoxide reductase. | 2008 | Vitam. Horm. | pmid:18374192 |
| Berkner KL | Vitamin K-dependent carboxylation. | 2008 | Vitam. Horm. | pmid:18374193 |
| Bügel S | Vitamin K and bone health in adult humans. | 2008 | Vitam. Horm. | pmid:18374202 |
| Shearer MJ et al. | Studies on the absorption and metabolism of phylloquinone (vitamin K1) in man. | 1974 | Vitam. Horm. | pmid:4617407 |
| Gumulec J et al. | [Hemorrhagic complications during warfarin treatment]. | 2006 | Vnitr Lek | pmid:16637455 |
| PATSCH J | [CONSTITUTION, STRESS AND BLOOD COAGULATION]. | 1964 | Wien Med Wochenschr | pmid:14237308 |
| Fischer M et al. | [The therapeutic management of consumption coagulopathy in progressive liver cirrhosis: low-dosage heparin therapy (author's transl)]. | 1976 | Wien. Klin. Wochenschr. | pmid:997529 |
| Du W et al. | Vitamin K1 enhances sorafenib-induced growth inhibition and apoptosis of human malignant glioma cells by blocking the Raf/MEK/ERK pathway. | 2012 | World J Surg Oncol | pmid:22520038 |
| Sloane N | Enzymic hydroxylation of benzo(alpha)pyrene at the 6-position by vitamin K1-hydroperoxide and rat lung hydroperoxidase. | 1981 | Xenobiotica | pmid:6272502 |
| Hayakawa Y and Takamura K | [Reaction of vitamin K3 with cysteine in aqueous ethanol and consecutive determination of vitamins K (author's transl)]. | 1974 | Yakugaku Zasshi | pmid:4476774 |
| Nakata Y et al. | [Studies on photodegradation of vitamin K1. I. Determination of vitamin K1 by gas-liquid chromatography (author's transl)]. | 1976 | Yakugaku Zasshi | pmid:943509 |
| Hiroshima O et al. | [Determination of phylloquinone-2,3-epoxide and menaquinone-4-2,3-epoxide in biological materials by high performance liquid chromatography and fluorometric reaction detection (author's transl)]. | 1979 | Yakugaku Zasshi | pmid:544742 |